Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy

Oncogene volume 22, pages 3539–3547 (2003)Cite this article

Abstract

Increased survivin expression is a negative prognostic marker in many tumours, including ovarian cancer. We show here that ovarian carcinoma cells upregulate survivin transcription in response to increased expression of the proapoptotic protein procaspase 3. We have utilized this observation in a combination gene therapy strategy using adenoviral constructs expressing the dominant-negative mutant survivin T34A (Ad Survivin T34A) and procaspase 3 (Ad Caspase 3) in ovarian carcinoma cell lines. Transfection of ovarian carcinoma cells with Ad Survivin T34A induces apoptosis via a caspase 9-mediated pathway that is not affected by cell cycle block prior to G2/M. Ad Survivin T34A-induced apoptosis can be significantly enhanced by cotransfection with Ad Caspase 3, and the combination of Ad Survivin T34A and Ad Caspase 3 leads to a significant increase in survival in a murine intraperitoneal ovarian carcinoma model with some long-term survivors. This suggests that inhibiting endogenous survivin activity while also delivering high levels of procaspase 3 allow proteolytic cleavage and activation of the terminal caspase cascade leading to tumour cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Adams RR, Carmena M and Earnshaw WC . (2001). Trends Cell Biol., 11, 49–54.

  • Ambrosini G, Adida C, Sirugo G and Altieri DC . (1998). J. Biol. Chem., 273, 11177–111782.

  • Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D and Watanabe N . (2000). Jpn. J. Cancer Res., 91, 1204–1209.

  • Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H and Ng SC . (2000). Blood, 96, 4002–4003.

  • Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC and Altieri DC . (2002). Nat. Med., 8, 987–994.

  • Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES and Cohen GM . (2001). EMBO J., 20, 998–1009.

  • Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y . (2000). Nature, 406, 855–862.

  • Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC and Ng SC . (2000). Neoplasia, 2, 235–241.

  • Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, Baens M, Collen D and Schuh AC . (2000). Blood, 95, 1435–1442.

  • Deveraux QL, Takahashi R, Salvesen GS and Reed JC . (1997). Nature, 388, 300–304.

  • Dong Z, Nishiyama J, Yi XL, Venkatachalam MA, Denton M, Gu SM, Li SL and Qiang M . (2002). Biochem. J., 364, 413–421.

  • Du C, Fang M, Li Y, Li L and Wang X . (2000). Cell, 102, 33–42.

  • Grossman D, Kim PJ, Schechner JS and Altieri DC . (2001). Proc. Natl. Acad. Sci. USA, 98, 635–640.

  • He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B . (1998). Proc. Natl. Acad. Sci. USA, 95, 2509–2514.

  • Ikeguchi M, Nakamura S and Kaibara N . (2002). Oncol. Rep., 9, 1121–1126.

  • Kovarik A, Peat N, Wilson D, Gendler S and Taylor-Papadimitriou J . (1993). J. Biol. Chem., 268, 9917–9926.

  • Lavoie JN, Nguyen M, Marcellus RC, Branton PE and Shore GC . (1998). J. Cell Biol., 140, 637–645.

  • Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC . (1999). Nat. Cell Biol., 1, 461–466.

  • Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC . (1998). Nature, 396, 580–584.

  • Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A and Korneluk RG . (1996). Nature, 379, 349–353.

  • Livne A, Shtrichman R and Kleinberger T . (2001). J. Virol., 75, 789–798.

  • McNeish IA, Tenev T, Bell S, Marani M, Vassaux G and Lemoine N . (2001). Cancer Gene Ther., 8, 308–319.

  • Mesri M, Wall NR, Li J, Kim RW and Altieri DC . (2001). J. Clin. Invest., 108, 981–990.

  • Nicholson D . (1999). Cell Death Differ., 6, 1028–1042.

  • O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC . (2000). Proc. Natl. Acad. Sci. USA, 97, 13103–13107.

  • Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ . (2000). Gut, 46, 645–650.

  • Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM and Slawin KM . (2001). Cancer Res., 61, 2562–2571.

  • Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK and Oh BH . (2001). Biochemistry, 40, 1117–1123.

  • Shinoura N, Muramatsu Y, Yoshida Y, Asai A, Kirino T and Hamada H . (2000). Exp. Cell Res., 256, 423–433.

  • Silke J, Ekert PG, Day CL, Hawkins CJ, Baca M, Chew J, Pakusch M, Verhagen AM and Vaux DL . (2001). EMBO J., 20, 3114–3123.

  • Silke J and Vaux DL . (2001). J. Cell Sci., 114, 1821–1827.

  • Skoufias DA, Mollinari C, Lacroix FB and Margolis RL . (2000). J. Cell Biol., 151, 1575–1582.

  • Speliotes EK, Uren A, Vaux D and Horvitz HR . (2000). Mol. Cell, 6, 211–223.

  • Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K and Shiraki K . (2000). Oncogene, 19, 3225–3234.

  • Takahashi R, Deveraux Q, Tamm I., Welsh K, Assa-Munt N, Salvesen GS and Reed JC . (1998). J. Biol. Chem., 273, 7787–7790.

  • Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC . (1998). Cancer Res., 58, 5315–5320.

  • Tenev T, Marani M, McNeish I and Lemoine NR . (2001). Cell Death Differ., 8, 256–264.

  • Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL and Choo KH . (2000). Curr. Biol., 10, 1319–1328.

  • Vasquez RJ, Howell B, Yvon AM, Wadsworth P and Cassimeris L . (1997). Mol. Biol. Cell, 8, 973–985.

  • Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T and Noel JP . (2000). Nat. Struct. Biol., 7, 602–608.

  • Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL . (2000). Cell, 102, 43–53.

  • Wall NR, O'Connor DS, Plescia J, Pommier Y and Altieri DC . (2003). Cancer Res., 63, 230–235.

  • Yamabe K, Shimizu S, Ito T, Yoshioka Y, Nomura M, Narita M, Saito I, Kanegae Y and Matsuda H . (1999). Gene Therapy., 6, 1952–1959.

  • Yoshida H, Ishiko O, Sumi T, Matsumoto Y and Ogita S . (2001). Int. J. Oncol., 19, 537–542.

  • Zhao J, Tenev T, Martins LM, Downward J and Lemoine NR . (2000). J. Cell Sci., 113, 4363–4371.

  • Zou H, Li Y, Liu X and Wang X . (1999). J. Biol. Chem., 274, 11549–11556.

Download references

Author information

Authors and Affiliations

  1. Cancer Research UK Molecular Oncology Unit, Imperial College School of Medicine, Hammersmith Hospital, London, W12 0NN, UK

    Tristan R McKay, Stephen Bell, Tencho Tenev, Viola Stoll, Rita Lopes, Nicholas R Lemoine & Iain A McNeish

Authors
  1. Tristan R McKay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tencho Tenev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Viola Stoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rita Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicholas R Lemoine
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Iain A McNeish
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iain A McNeish.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKay, T., Bell, S., Tenev, T. et al. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. Oncogene 22, 3539–3547 (2003). https://doi.org/10.1038/sj.onc.1206417

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206417

Keywords

This article is cited by

Search

Advanced search

Quick links